# Ascend Advanced Therapies (Ascend Advanced Therapies Limited)

Private limited company registered in London, classed under “Manufacture of pharmaceutical preparations” and 1 other activity.

- Company number: 13471083
- Status: Active
- Type: Private limited company
- Incorporated: 22 June 2021
- Registered office: Suite 1, 7th Floor, 50 Broadway, London, SW1H 0DB
- Location: London
- Activity: Manufacture of pharmaceutical preparations

## Latest filed profit

Profit after tax in the year to 31 December 2024: **loss of £22.4m**, from its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Ascend Advanced Therapies do?

Private limited company registered in London, classed under “Manufacture of pharmaceutical preparations” and 1 other activity.

### How much turnover does Ascend Advanced Therapies make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/ascend-advanced-therapies-13471083

### Is Ascend Advanced Therapies profitable?

No: it made a loss after tax of £22.4m in the year to 31 December 2024, its latest filed accounts.

### How many people work at Ascend Advanced Therapies?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/ascend-advanced-therapies-13471083

### Who runs and owns Ascend Advanced Therapies?

Its directors are Per Fredrik Thorell. Its owners are shown to subscribers.

### Where is Ascend Advanced Therapies based?

Its registered office is Suite 1, 7th Floor, 50 Broadway, London, SW1H 0DB, in London.

### When was Ascend Advanced Therapies founded?

Ascend Advanced Therapies Limited was incorporated on 22 June 2021.

### Is Ascend Advanced Therapies still trading?

The register lists Ascend Advanced Therapies Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-07-23: Group of companies' accounts made up to 31 December 2024
- 2026-02-13: Registered office address changed from 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom to Suite 1, 7th Floor 50 Broadway London SW1H 0DB on 13 February 2026
- 2026-02-10: Appointment of Mr per Fredrik Thorell as a director on 20 January 2026
- 2026-02-10: Termination of appointment of Michael Anthony Stella as a director on 20 January 2026
- 2026-01-29: Termination of appointment of Oakwood Corporate Secretary Limited as a secretary on 22 January 2026
- 2025-12-03: Compulsory strike-off action has been discontinued
- 2025-12-02: First Gazette notice for compulsory strike-off
- 2025-07-17: Termination of appointment of Errett Wesley Mcconnell Iii as a director on 3 June 2025
- 2024-11-26: Resolutions (and 3 more like it since 1 March 2023)
- 2024-11-19: Termination of appointment of Justin Wesley Kern as a director on 6 November 2024
- 2024-11-19: Termination of appointment of Fred Cohen as a director on 6 November 2024
- 2024-11-19: Termination of appointment of Andrey Kozlov as a director on 6 November 2024
- 2024-11-19: Termination of appointment of Balaji Muralidhar as a director on 6 November 2024
- 2024-11-19: Termination of appointment of Andrew Sinclair as a director on 6 November 2024
- 2024-11-19: Termination of appointment of Michael Charles Beecham as a director on 6 November 2024
- 2024-11-19: Termination of appointment of Timothy Michael Funnell as a director on 6 November 2024
- 2024-11-19: Appointment of Errett Wesley Mcconnell Iii as a director on 6 November 2024
- 2024-11-17: Memorandum and Articles of Association (and 4 more like it since 6 March 2023)
- 2024-11-13: Cancellation of shares. Statement of capital on 6 November 2024 · GBP 1,215.40341 (and 3 more like it since 17 January 2023)
- 2024-11-13: Purchase of own shares (and 3 more like it since 17 January 2023)
- 2024-10-14: Particulars of variation of rights attached to shares (and 17 more like it since 17 January 2023)
- 2024-10-14: Change of share class name or designation (and 17 more like it since 18 January 2023)
- 2024-07-30: Appointment of Justin Wesley Kern as a director on 22 July 2024
- 2024-07-29: Termination of appointment of Eric Norio Shiozaki as a director on 22 July 2024
- 2024-06-24: Group of companies' accounts made up to 31 December 2023

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/ascend-advanced-therapies-13471083